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Abstract
Background: A deeper knowledge on the effects of the 
degradation of magnetic nanoparticles on their magnetic 
properties is required to develop tools for the identifica-
tion and quantification of magnetic nanoparticles in bio-
logical media by magnetic means.
Methods: Citric acid and phosphonoacetic acid-coated 
magnetic nanoparticles have been degraded in a medium 
that mimics lysosomal conditions. Magnetic measure-
ments and transmission electron microscopy have been 
used to follow up the degradation process.
Results: Particle size is reduced significantly in 24 h at pH 
4.5 and body temperature. These transformations affect 
the magnetic properties of the compounds. A reduction of 
the interparticle interactions is observed just 4 h after the 
beginning of the degradation process. A strong paramag-
netic contribution coming from the degradation products 
appears with time.
Conclusions: A model for the in vivo degradation of mag-
netic nanoparticles has been followed to gain insight on 
the changes of the magnetic properties of iron oxides dur-
ing their degradation. The degradation kinetics is affected 
by the particle coating, in our case being the phosphono-
acetic acid-coated particles degraded faster than the citric 
acid-coated ones.
Keywords: biomedical applications; iron oxides; magh-
emite; magnetic characterization.
Background
The number of biomedical applications for magnetic 
nanoparticles has grown steadily in the last few years 
[8]. In addition to the most widely developed applica-
tions, such as contrast agents for magnetic resonance 
imaging (MRI) [31], heating mediators for magnetic 
hyperthermia in cancer treatment [18], and drug deliv-
ery systems [11], novel applications include the use of 
magnetic particles for wound healing [3, 26], stroke 
treatment [2], tissue engineering [29], and parasite 
 diagnosis [5]. In this scenario, it is necessary to specifi-
cally produce compounds with structural characteris-
tics  suitable for each  application [14].
A few remaining challenges need to be addressed 
before the use of nanoparticles is widely accepted in bio-
medical applications. First, detailed knowledge of the 
particle toxicity is required before the material reaches the 
clinical practice. The toxic potential of the particles has 
been thoroughly analyzed in cell cultures [4]; however, 
3D cell cultures may behave in a different way to their 2D 
counterparts [20]. Moreover, although the particle toxicity 
could be low, little information is usually collected on the 
toxicity of the particle degradation products.
When the analysis shifts from cells to animals, a 
number of issues arise. It is still not clear how to control 
the particle biodistribution once they have been admin-
istered. Novel approaches include testing the advantages 
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of using external magnetic fields [15], special antibodies 
[30], or specific particle coatings [7] to selectively target 
the area of interest to treat a disease or diagnose it. In addi-
tion, the fate of the particles after systemic injection has 
not been properly characterized, i.e., the residence time of 
the particles in tissues and the metabolic routes activated 
during the particle degradation need to be assessed.
Only a few studies on the biodistribution and degra-
dation of magnetic nanoparticles in animal models have 
been reported, mainly due to the difficulties in analyzing 
the particles in tissue matrices, particularly as the animal 
size increases. Most of the biomedical applications require 
small amounts of material to achieve the desired effect; 
therefore, in animal experiments, the particles end up 
being extremely diluted within tissue matrices, hindering 
the evaluation of their degradation processes. One of the 
biggest problems faced in the characterization of magnetic 
nanoparticles in tissues arises from the fact that most par-
ticles used for biomedical applications are based on iron 
oxides, and there is a large amount of endogenous iron 
already in the tissues. Thus, the distinction between the 
iron from the particles and endogenous iron present in the 
tissue is a complicated task [6]. Techniques that exploit the 
specific magnetic properties of the particles and, there-
fore, discern them from tissue iron-containing species are 
currently being used to analyze magnetic nanoparticles 
in tissue samples, in particular electron spin resonance 
(ESR) [6], ferromagnetic resonance [12], field-dependent 
magnetization [28], or alternating current (AC) magnetic 
susceptibility [16] measurements. In the latter case, the 
temperature dependence of the AC magnetic susceptibility 
has been proven to be a powerful tool for the quantitative 
analysis of magnetic nanoparticles and biogenic species 
in animal tissue samples, as it allows the study of the par-
ticle biodistribution and degradation processes [27]. Of 
special interest is the fact that both diamagnetic and para-
magnetic contributions to the out-of-phase susceptibility 
are zero, allowing the facile determination of the presence 
of magnetic nanoparticles and/or biomineral iron (e.g., 
ferritin, the iron storage protein) [17]. However, there are 
still a few remaining issues which will need to be solved 
before this technique can be adopted as a gold standard 
for the study of the magnetic nanoparticle fate. When 
studying the presence of magnetic nanoparticles in tissue 
samples during their degradation, the temperature posi-
tion of the out-of phase susceptibility maxima is mainly 
affected by two parameters, the interparticle interactions 
and the particle size reduction due to their degradation. 
Both the disaggregation of the particles reducing the 
interparticle interactions and the degradation of the par-
ticles reducing their size, shift the temperature position 
of the out-of-phase susceptibility maxima toward lower 
temperatures [17]. Therefore, the identification of which of 
the two processes is being observed is not obvious when 
a shift on the temperature location is observed with time.
The aim of our work is to shed some light on the evolu-
tion of the magnetic properties of iron oxide nanoparticles 
during a degradation process that mimics in vivo condi-
tions. In particular, we focus on the effect of the particle 
degradation on the temperature dependence of the AC 
magnetic susceptibility of the particles, as this technique 
has been revealed as a powerful technique for quantita-
tive analysis of magnetic nanoparticles and biogenic 
species in animal tissue samples. The development of 
standards that mimic the degradation processes in tissues 
is fundamental to quantify the presence of nanoparticles 
in tissues and follow its long-term transformation.
Methods
Magnetic nanoparticle synthesis
Iron oxide magnetic nanoparticles (MNPs) were synthesized in aque-
ous media, following a modified Massart method [25]. Briefly, 75 ml 
of a NH4OH solution (25%, from Fluka – Riedel de Haën, Germany) 
was rapidly added to a solution of FeCl2 (0.175 m, from Sigma Aldrich, 
Germany, ≥99.0%) and FeCl3 (0.334  m, from VWR International, 
France, 27% Aqueous solution). The addition was carried out at room 
temperature under vigorous stirring. After 5 min, the sample was 
washed three times with distilled water by magnetic decantation. 
Particles were then treated with nitric acid and iron nitrate to fully 
oxidize the magnetic iron oxide to maghemite, activate their surface, 
and improve the colloidal properties [9]. In addition, maghemite 
(Fe3O4) is a more stable iron oxide phase, and up to now, the only one 
approved by the FDA (U.S. Food and Drug Administration) for in vivo 
administration. Briefly, the particles were treated with 300 ml of 2 m 
aqueous solution of HNO3 (from Sigma Aldrich, Germany, ≥65%) and 
stirred for 15 min. Then, the super natant was removed, and 75 ml of 
aqueous solution of Fe(NO3)3 (1 m, from Sigma Aldrich, Spain, ≥98%) 
and 130 ml of distilled water were added, followed by refluxing for 
30 min. After cooling down and removing the supernatant, 300 ml of 
2 m aqueous solution of HNO3 was added, and the sample was stirred 
for 15 min. The sample was washed three times with acetone and re-
dispersed in distilled water. The acetone residue was rota-evaporated 
and the resulting product named MNPs.
Particles (MNPs) were subsequently coated with two different 
anionic compounds, citric acid (from Sigma Aldrich, Austria, ≥99.5%) 
and phosphonoacetic acid (from Sigma Aldrich, Canada, 98%). We 
used a standard procedure to generate the citric acid-coated magnetic 
nanoparticles (CIT-MNPs) [21, 24]. Briefly, 40 ml of a solution of 0.1 m 
 citric acid was added dropwise to 50 ml of treated sample ([Fe]≈20 mg/
ml) at pH 3 before being heated at 80°C for 30  min under vigorous 
mechanical stirring.
Phosphonoacetic acid-coated magnetic nanoparticles (PAA-
MNPs) were prepared following a protocol that has been previously 
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described [10]. Briefly, 10 ml of acid-treated sample ([Fe]≈77 mg/ml) 
was dispersed in 50 ml of distilled water at pH 2.5. Then, 40 ml of a 
solution of 0.05 m phosphonoacetic acid was added dropwise under 
sonication. Samples were sonicated in a bath during 30 min, after 
which time the dispersion became turbid due to the coating of the 
nanoparticles.
For both samples, the excess of the coating was washed by cen-
trifugation and dialyzed in 5 l of distilled water by using a membrane 
with a 12,000–14,000 nominal molecular weight cut off. The pH of 
the dispersions was adjusted first to 11 with 1 m KOH (from Sigma 
Aldrich, Czech Republic, ≥85%) and then to 7 with 1 m HNO3, and PBS 
buffer (from Sigma Aldrich, USA) was added in the same conditions 
that would be used for in vivo applications.
Degradation of magnetic nanoparticles mimicking 
 lysosomal conditions
The effect of the pH on the kinetics of the degradation process was 
evaluated at room temperature during 15  days using citrate buffer 
solutions at different concentrations of citric acid (20 mmol/l, from 
Sigma-Aldrich, Austria,  > 99.5%) and different pHs (2.5, 3.5, and 4.5), 
conditions that have been previously used by Lévy et al. [22]. Differ-
ent volumes of the synthetized particles were added to the citrate 
buffer solutions to reach a final iron concentration of 1 mmol/l. A 
second experiment was prepared, using higher temperatures (37°C), 
to simulate body temperature, and pH 4.5, to mimic lysosomal condi-
tions, similar to the protocol described by Arbab et al. [1]. The deg-
radation medium with the particles was split into several tubes and 
placed in a hot block. The degradation was stopped at 0 h, 4 h, and 
24 h by either freezing the samples at -20°C or drying the sample for 
the transmission electron microscopy (TEM) observation. The hydro-
dynamic size measurements that require liquid samples were per-
formed immediately at these time points.
Magnetic nanoparticle characterization
Iron determination was carried out in an inductively coupled plasma-
optical emission spectrometry (ICP-OES) apparatus, OPTIME 2100DV 
from Perkin Elmer (USA) after acid digestion.
Structural characterization: The crystal structure of the as-syn-
thetized nanoparticles was identified by X-ray powder diffraction 
performed in a Bruker (USA) D8 Advance powder diffractometer by 
using the CuKα radiation with an energy-discriminator (Sol-X) detec-
tor. Infrared spectra of the original samples diluted in 2% KBr were 
recorded between 4000 and 250  cm-1 in a Bruker (USA) IFS 66V-S 
spectrometer and a Nicolet FT-IR 20SXC (Thermo Scientific, USA). 
Thermal analysis was performed to quantify the amount of coating 
molecules on the particle surface. Simultaneous thermogravimetric 
(TG) and differential thermal analysis (DTA) were performed on a 
Seiko TG/DTA 320U thermobalance (Seiko Instruments, Japan). Sam-
ples were heated from room temperature to 900°C at 10°C/min under 
an air flow of 100 ml/min.
Size analysis: A Zetasizer nano ZS by Malvern Instruments (UK) 
was used to determine both the hydrodynamic size and Z-potential.
To minimize the effect of multiple scattering in the hydrody-
namic size distribution analysis, measurements at three different 
sample concentrations were performed. The result with the higher 
count number and the best position was selected as correct. It is 
worthy to mention that although the fundamental size distribution 
generated by dynamic light scattering (DLS) measurements is an 
intensity distribution, this can be converted to a volume distribution 
using the refraction index (2.42 for maghemite) and the Mie theory. 
This volume distribution can be further converted to a number dis-
tribution; however, number distributions are of limited use as small 
errors in gathering data could lead to huge errors in distribution by 
number. In most of the experiments of this work, the hydrodynamic 
size distribution is measured in terms of volume instead of intensity. 
When we measure in intensity mode, we are overestimating the con-
tribution of the large particles. This is because large particles scatter 
much more light than small particles (the intensity of scattering of 
a particle is proportional to the sixth power of its diameter – from 
Rayleigh’s approximation).
Particle core size was determined from TEM micrographs using 
a JEOL JEM1010 (100 KV) microscope (Japan). For observation of the 
sample in the microscope, particles were dispersed in isopropanol or 
water, and a drop of the suspension was placed onto a copper grid 
covered by a carbon film and allowed to dry at room temperature. 
Mean particle size and distribution were evaluated by measuring the 
largest internal dimension of at least 150 particles.
Magnetic characterization: For the magnetic characterization 
of the degradation products, liquid samples were frozen once the 
desired degradation time was reached and freeze dried overnight in a 
LyoQuest freeze dryer (Telstar, Spain). The resulting solid sample was 
compacted into gelatin capsules for magnetic characterization. This 
sample preparation procedure prevents particle movement through 
Brown rotation in an alternating field. Hysteresis loops with a maxi-
mum field of 5 T were measured in a Vibrating Sample Magnetom-
eter (MLVSM9, MagLab 9T, Oxford Instruments, UK). AC magnetic 
susceptibility measurements were performed in a Quantum Design 
(USA) MPMS-XL SQUID magnetometer with magnetic field amplitude 
of 0.41 mT and a frequency of 11 Hz in the temperature range between 
2 and 300 K.
Results
As-synthetized magnetic nanoparticle 
characterization
Maghemite nanoparticles with nearly spherical morphol-
ogy and an average size of around 6.5 nm, measured 
from TEM images, were obtained by the coprecipitation 
method and subsequent acid treatment. The X-ray dif-
fraction spectra from the magnetic nanoparticles were 
indexed to an inverse spinel structure (JCPDS 39-1346) 
(Figure 1). The average crystallite size was calculated by 
Scherrer’s formula using the half width of the (311) X-ray 
diffraction peak to be 6 nm, in agreement with the TEM 
observations. The average particle size of the coated parti-
cles was 6.5±1.7 nm and 6.8±1.8 nm for the citric acid and 
phosphonoacetic acid coatings, respectively (Figure 2). No 
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Figure 2: Size reduction during the degradation process mimicking 
lysosomal conditions (37°C, pH = 4.5).
Transmission electron micrographs of the particles at the initial 
(A and B) and final points (C and D) of the degradation process 
together with the particle core size distribution measurements 
obtained from the TEM images (E and F).
Figure 1: Particle’s characterization.
(A) XRD pattern of the sample MNPs prior to the coating procedure, 
(B) Z-Potential versus pH, and (C) FTIR spectra of the uncoated 
maghemite nanoparticles and the citric acid and phosphonoacetic 
acid-coated nanoparticles.
significant size modification was observed after the parti-
cle coating, as both samples were prepared from the same 
batch of magnetic cores.
The FTIR spectra of the maghemite nanoparticles 
before and after the coatings are shown in Figure 1. The 
typical bands of maghemite are centered at 640, 575, 440, 
and 400 cm-1. A sharp band at 1381 cm-1 is due to the pres-
ence of nitric acid, which is used during the acid treat-
ment to oxidize the particles and to adjust the pH of the 
samples. Bands at 1630 and 3440 cm-1 are typical of water 
chemi- or physi-sorbed onto the particle surface. The pres-
ence of the coating molecules onto the particle surface is 
evidenced by the bands between 1250 and 800 cm-1: In the 
phosphonoacetic acid-coated nanoparticles, the presence 
of adsorption band at 980 and around 1208 cm-1 would be 
characteristic of POH and P = O stretching bands, respec-
tively, while the P-O stretching bands are forming a broad 
band at 1036 cm-1. On the other hand, samples coated with 
citric acid present bands at 1070 cm-1, which correspond to 
the ρ-(CH3) vibrations, while bands at 1112 and 1260 cm-1 
are attributable to ν-(C-OH) and the carboxylic group, 
respectively.
Consequently, a shift in the isoelectric point was 
observed from pH 7 (MNPs) to 4.4 and 2.8 for the parti-
cles coated with citric acid and phosphonoacetic acid, 
respectively. Thus, at pH 7, coated particles were electro-
statically stabilized on the light of the large Z-potential 
values: -26  and -32  mV for samples PAA-MNPs and CIT-
MNPs, respectively. As a result of these large surface 
charges, particles were colloidally stable, and the average 
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hydrodynamic size of both samples was below 100 nm at 
the initial time point of the degradation process.
Thermal analysis revealed a total weight loss of 
around 10% (10.23% and 9.7% for CIT-MNPs and PAA-
MNPs, respectively). In both cases, the majority of the 
weight loss takes place before 400°C due to the organic 
content of the coating molecules.
Degradation process
The degradation process was followed for 15 days by the 
observation of the color transformations of the particles 
placed in citrate buffer at three different pHs (2.5, 3.5 and 
4.5) at room temperature (Figure 3). The color change, from 
the brown color of the original maghemite suspension to 
the yellow color typical of free iron ions, was fastest at 
the lowest pH. A very similar trend was observed for both 
kinds of coatings. At pH 4.5, the most similar to lysosomal 
conditions, complete degradation of the particles was not 
observed after 2 weeks.
In order to accelerate the process and also to achieve 
conditions more similar to the physiological medium, the 
degradation of the particles was then performed at pH 4.5 
and 37°C. A significant color change from dark orange to 
yellow occurred within 24 h (Figure 4). After this period of 
time, particle size was significantly reduced to be 5.0±1.6 
for the CIT-MNPs (p < 0.0001) and 4.4±2.1 for the PAA-
MNPs (p < 0.0001) (Figure 2). At the beginning of the citric 
Figure 4: Degradation process in physiological conditions (37°C, 
pH = 4.5).
Visual follow-up of the magnetic nanoparticle suspensions during 
the degradation process.
Figure 3: Degradation process at room temperature at different pHs.
Visual follow-up of the magnetic nanoparticle suspensions during 
the degradation process at three different pHs.
acid-coated particle degradation experiment, the size of 
most particles (75%) was in the 5- to 8-nm range, whereas 
after 24 h, 62% of the particles presented a size in the 3- 
to 5-nm range. A similar behavior was observed for the 
PAA-MNPs, where at the initial time, 64% of the particles 
present a size in the range between 5 and 8 nm, while after 
24 h, most of the particles (65%) presented sizes in the 
2- to 5-nm range. The final particle size distribution after 
24  h degradation was significantly different (p = 0.001) 
between citric acid and phosphonoacetic acid coatings. It 
seems that PAA-MNPs degrade faster than the citric acid-
coated ones.
As shown in Figure 2, particle degradation within 
each aggregate seems to be faster for those particles on the 
surface of the aggregate, meaning that the degradation 
process does not occur at the same speed for all  particles. 
Therefore, degradation kinetics is probably related to the 
aggregation status. The degradation process was also 
observed through the reduction of the particle hydrody-
namic size with time (Figure 5).
Field-dependent magnetization results, scaled to 
the magnetization values at the highest field (Mmax), are 
shown in Figure 6 for the citric acid-coated magnetic 
Brought to you by | CSIC - Unidad Coordinacion Bibliotecas
Authenticated
Download Date | 10/9/17 9:15 AM
422      L. Gutiérrez et al.: Nanoparticle degradation followed by AC susceptibility
nano particles. Similar results were observed for the PAA-
MNPs. As expected, at 290 K, a decrease in the satura-
tion magnetization is observed (≈fivefold within the 24-h 
degradation process). In addition, at 5 K, the appearance 
of a significant paramagnetic contribution is observed 
with time, probably related to the presence of iron citrate 
complexes. At low temperatures, the paramagnetic con-
tribution dominates the signal in comparison with the 
nanoparticle contribution, and this phenomenon compli-
cates the quantitative analysis of the particle degradation.
The temperature dependence of the AC magnetic sus-
ceptibility, both the in-phase (χ′(T)) and the out-of-phase 
susceptibility (χ″(T)) components are shown in Figure  7. 
Above 200 K, the out-of-phase susceptibility is zero within 
the accuracy of the experiments. The in-phase suscepti-
bility shows a maximum at around 80 K at the beginning 
of the degradation experiment for both kinds of particles, 
accompanied by an out-of-phase susceptibility maximum 
at around 50 K, related to a relaxation process.
During the degradation experiment, the temperature 
location of the χ′ and χ″ maxima shifts toward lower tem-
peratures reaching 35–40 K for the out-of-phase suscep-
tibility component after 4  h under lysosomal conditions 
(37°C and pH = 4.5).
The samples prepared at the final time point, 24  h 
after the beginning of the experiment, present a differ-
ent behavior. The in-phase susceptibility shows a Curie 
law behavior typical of paramagnetic species, indicating 
the degradation of the crystalline structure and the gen-
eration of other species, probably iron atoms chelated by 
citrates. The out-of-phase susceptibility presents a noisy 
maximum located at the lowest temperatures, at around 
27  K for the citric acid-coated particles. The low signal 
Figure 6: Field-dependent magnetization measurements during the 
degradation process.
Measurements have been performed at two different temperatures: 
290 K and 5 K.
Figure 5: Hydrodynamic sizes during the degradation process (37°C, pH = 4.5).
Hydrodynamic diameter measured by DLS at three points during the degradation process.
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indicates that there is a very small fraction of the sample 
that is still in the form of magnetic nanoparticles.
To evaluate the importance of interparticle interac-
tions, τ0 values have been calculated. This parameter 
is the pre-exponential factor that appears in the Arrhe-
nius expression for the relaxation time, τ = τ0 exp(Ea/
kBT), where kB is the Boltzmann constant and Ea, the 
single particle anisotropy energy barrier. τ0 values in the 
range between 10-9 and 10-12  s indicate negligible inter-
particle interactions [13]. A method to calculate τ0 has 
been described by López et al. [23], based on the com-
plementarity of the relaxational information in χ′ and 
χ″. Using this method, τ0 values have been calculated for 
the 0 h and 4 h time points. In samples with both coat-
ings, τ0 values shift from 10-13 s at the initial time point 
to 10-11  s after 4  h of the degradation process, indicat-
ing a reduction of the interparticle interactions during 
the degradation process. These results are in agreement 
with the hydrodynamic size reduction observed by DLS 
(Figure 5).
Discussion
The size reduction of around 15% of the particle diame-
ter for the citric acid-coated particles, from 6.5±1.7 nm to 
5.6±2.4 nm, is responsible for a temperature shift of the 
out-of-phase susceptibility maximum from 50 to ≈27 K, 
reflecting the high sensitivity of these measurements to 
small changes in particle volume. These differences are 
also in agreement with the ≈fivefold reduction of the satu-
ration magnetization within the 24-h degradation process.
A faster degradation process has been observed for 
PAA-MNPs in comparison with CIT-MNPs, revealing the 
Figure 7: AC magnetic susceptibility measurements during the degradation process.
Temperature dependence of the in-phase and out-of-phase susceptibility for the two kinds of particles at three times during the degrada-
tion process (0 h, 4 h, and 24 h). The line from the samples degraded during 24 h corresponds to a polynomial fit of the data points.
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importance of the particle coating on the degradation 
process. In our case, magnetic cores were prepared in the 
same batch and subsequently coated by two different pro-
cedures, allowing the study of the role of the coating on 
the degradation process without overlapping other effects 
coming from the use of different cores, as in previous 
works [22].
This study is a simple approximation to the degrada-
tion processes occurring in biological matrices; a more 
complex approach should include biological serum 
proteins (e.g., fetal bovine serum) in the degradation 
solution. It has been previously demonstrated how the 
formation of a protein corona in the organic media affects 
the hydrodynamic size of the particles and how the differ-
ent particle coatings affect the formation of this protein 
corona [32]. Therefore, one could envisage a substantial 
effect of the protein corona on the degradation kinetics of 
the particles.
A shift of the temperature location toward lower tem-
peratures has also been previously observed in animal 
models monitored during long time periods after the 
administration of magnetic nanoparticles [27]. In the case 
of animal tissues, however, it is difficult to distinguish a 
reduction in the particle size from a possible reduction of 
the dipolar interactions due to disaggregation processes 
[15, 23]. Indeed, one of the challenges of using AC mag-
netic susceptibility measurements to evaluate the trans-
formations suffered by magnetic nanoparticles in animal 
models would be to develop protocols to distinguish the 
processes behind the χ″(T) maxima shift.
When thinking of the possible degradation mecha-
nisms, one can envisage a process where all the parti-
cles reduce their size homogeneously. However, we have 
found that although part of the magnetic nanoparticles 
suffers a significant reduction in the particle size, there 
is still another part that does not seem to be affected by 
the degradation process. In previous works, the important 
role played by the coating on the selection of the particles 
that will degrade in the first place has been described. It 
seems that the areas where the coating is less dense are 
prone to be the ones where the degradation starts [19]. Our 
work has also shown that particle aggregation is an addi-
tional important factor affecting the particle degradation. 
Thus, particles in the outer layer of the aggregate are first 
and severely affected by degradation while particles in the 
center are not affected in the first stadium of the process. 
This parameter strongly affects the analysis of the particles 
in tissue samples, as a different aggregation degree has 
been observed depending on the analyzed organ [15, 16].
For some biomedical applications, such as repeated 
MRI scans, slow kinetics of the magnetic nanoparticles 
forming the contrast agents may be desirable in a way that 
no additional injections are required each time an MRI 
image is needed. For some other uses, however, faster deg-
radation would be desirable. Therefore, a deeper study of 
the parameters that affect particle degradation is of great 
interest.
It is fundamental to gain a better understanding on 
the degradation process of MNPs and the effect on their 
magnetic properties. In this work, we have prepared 
standard samples that mimic the particle degradation 
that will be used in the future to determine, by magnetic 
means, the amount of particles in tissue samples in long-
term in vivo experiments.
Conclusions
The degradation of magnetic nanoparticles in a medium 
that mimics the lysosomal conditions has been followed 
by TEM, DLS, and AC magnetic susceptibility. The impor-
tant role of the coating on the degradation kinetics has 
been verified. Also, a nonhomogenous reduction of the 
particle size during the degradation process has been 
found. The high sensitivity of the AC magnetic suscepti-
bility measurements to particle size changes opens the 
way to novel approaches to evaluate the transformations 
of magnetic nanoparticles after systemic administration 
in animal models.
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